← Leaderboards
Benjamin Nicholson
Progenra, Inc.
$1,181,002
Attributed
$1,181,002
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $343K · FY2006–14$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,181,002 · 5
By mechanism
R43$1,181,002 · 5
Top collaborators
No co-investigators on record.
Most similar at Progenra, Inc.
Same institution · by research overlap
- Michael R Mattern$5,800,503
- David E Sterner$7,582,782
- Seth Goldenberg$265,823
- Kumar Suresh$5,007,499
- Joseph Weinstock$1,722,862
Others in their field
Top investigators on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$83,824,814
- Stuart L Schreiber · Harvard University (Medical School)$49,424,554
- Jay D Keasling · University Of California-Berkeley$47,558,861
- David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
EnzymesCellsInhibitor/AntagonistCollectionBaseProteinsPre-ClinicalPathway InteractionsLeadScreening ProcedureUbiquitinLibrariesPharmaceutical PreparationsDrug DiscoveryIn VivoSignal TransductionLinkMalignant NeoplasmsAdme StudyIsopeptidaseMarketingCell DeathFamilyHigh Throughput Screening
Grant awards (5)
Novel treatment for Huntington???s Disease$224,512
R43 · FY2014 · NS · contact PI
Identification of natural products to treat neoplastic disease$342,963
R43 · FY2012 · CA · contact PI
Targeting SUMO proteases for type II diabetes$271,286
R43 · FY2010 · DK · contact PI
Isopeptide inhibitors for cancer chemotherapy$192,441
R43 · FY2008 · CA · contact PI
b-TrCP E3 Ligase in CLL$149,800
R43 · FY2006 · CA · contact PI